Distinguished Professor Emeritus Erkki Ruoslahti, M.D., Ph.D., has been announced as one of three winners of the 2022 Albert Lasker Basic Medical Research Award, the most prestigious American award for biomedical research, for his transformational research leading to the discovery of the cell adhesion receptors now known as integrins.
We are honored to announce AivoCode’s Scientific Founder and Chairman, Erkki Ruoslahti has been named a Lasker Laureate.
Previous
Previous
AivoCode receives a $2.5M SBIR grant to develop a novel neurotherapeutic peptide for TBI
Next
Next